Macrogenics Inc (MGNX)
5.12
+0.41
(+8.70%)
USD |
NASDAQ |
May 16, 16:00
5.10
-0.02
(-0.39%)
After-Hours: 07:23
Macrogenics Accounts Payable (Quarterly): 10.69M for March 31, 2024
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 10.69M |
December 31, 2023 | 6.443M |
September 30, 2023 | 3.303M |
June 30, 2023 | 3.795M |
March 31, 2023 | 3.759M |
December 31, 2022 | 4.899M |
September 30, 2022 | 4.619M |
June 30, 2022 | 2.609M |
March 31, 2022 | 3.731M |
December 31, 2021 | 15.50M |
September 30, 2021 | 6.17M |
June 30, 2021 | 9.818M |
March 31, 2021 | 10.35M |
December 31, 2020 | 8.031M |
September 30, 2020 | 4.38M |
June 30, 2020 | 2.766M |
March 31, 2020 | 1.956M |
December 31, 2019 | 4.308M |
September 30, 2019 | 2.543M |
June 30, 2019 | 0.857M |
March 31, 2019 | 0.925M |
December 31, 2018 | 4.005M |
September 30, 2018 | 0.986M |
Date | Value |
---|---|
June 30, 2018 | 1.767M |
March 31, 2018 | 10.27M |
December 31, 2017 | 2.451M |
September 30, 2017 | 1.68M |
June 30, 2017 | 2.088M |
March 31, 2017 | 1.515M |
December 31, 2016 | 3.995M |
September 30, 2016 | 1.374M |
June 30, 2016 | 1.15M |
March 31, 2016 | 1.118M |
December 31, 2015 | 2.967M |
September 30, 2015 | 2.541M |
June 30, 2015 | 1.853M |
March 31, 2015 | 1.444M |
December 31, 2014 | 1.669M |
September 30, 2014 | 4.388M |
June 30, 2014 | 3.977M |
March 31, 2014 | 5.133M |
December 31, 2013 | 3.169M |
September 30, 2013 | 1.798M |
June 30, 2013 | 2.119M |
December 31, 2012 | 3.739M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
0.857M
Minimum
Jun 2019
15.50M
Maximum
Dec 2021
5.526M
Average
4.344M
Median
Accounts Payable (Quarterly) Benchmarks
Moderna Inc | 183.00M |
Allurion Technologies Inc | 10.38M |
United Therapeutics Corp | -- |
MEI Pharma Inc | 3.176M |
Marinus Pharmaceuticals Inc | 6.125M |